Clinical Trial Update: Effects Contrast on Platelet Activity, Thrombosis and Fibrinolysis in Patients Undergoing Coronary Angiography [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial conducted by NYU Langone Health assessed the effects of contrast agents on platelet activity, thrombosis, and fibrinolysis in patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: NYU Langone Health | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED | Results posted: 2016-04-06